YASEEN KADY: Open Payments
NPI 1053962233 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,385 in 132 payments from 29 companies in 2025. Trend: 2023 $4,018 · 2024 $4,547 · 2025 $6,385
Food & beverage: $3,450Travel & lodging: $1,310Consulting: $1,305Honoraria: $300Speaker / faculty: $20
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 13 | $3,269 |
| Amgen Inc. | 17 | $417 |
| Insulet Corporation | 11 | $371 |
| Corcept Therapeutics | 12 | $365 |
| Novo Nordisk Inc | 19 | $346 |
| Chiesi USA, Inc. | 2 | $326 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $194 |
| Averitas Pharma Inc. | 8 | $159 |
| ABBVIE INC. | 5 | $139 |
| Lilly USA, LLC | 8 | $128 |
Products named: Filspari, Omnipod, Korlym, JUXTAPID, KRYSTEXXA, JARDIANCE, Wegovy, QUTENZA.
Industry payments across CA — which companies pay providers there.
